1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Original Article
You have full text access to this OnlineOpen article
Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: An explanation for high acetaminophen dosage in humans without hepatic injury
Article first published online: 30 DEC 2003
DOI: 10.1002/hep.510290241
Copyright © 1999 American Association for the Study of Liver Diseases
1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
Additional Information
How to Cite
Shayiq, R. M., Roberts, D. W., Rothstein, K., Snawder, J. E., Benson, W., Ma, X. and Black, M. (1999), Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: An explanation for high acetaminophen dosage in humans without hepatic injury. Hepatology, 29: 451–463. doi: 10.1002/hep.510290241
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 15 OCT 1998
- Manuscript Received: 25 AUG 1998
Funded by
- R.M.S.
- Thomas Jefferson University
References
- 1
- 2. Reactive metabolites of phenacetin and acetaminophen: a review. Environ Health Perspect 1983; 49:71–79.MEDLINE
- 3, , , . Plasmaparacetamol halflife and hepatic necrosis in patients with paracetamol overdosage. Lancet 1971; 1:519–522.MEDLINE
- 4
- 5, . Recognising APAP hepatotoxicity in chronic alcoholics. Hepatotoxicity 1992; 91:241–245.
- 6
- 7, , . Severe APAP toxicity in a patient receiving isoniazid. Ann Intern Med 1990; 113:799–800.MEDLINE
- 8
- 9, , , . Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys 1989; 271:270–283.MEDLINE
- 10, , , , . Cytochrome P450–dependent metabolism of acetaminophen in four human transgenic lymphoblastoid cell lines. Pharmacogenetics 1994; 4:43–46.MEDLINE
- 11, , , , , , . Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol 1993; 6:511–518.MEDLINE
- 12, , , . Cytochrome P450 isozyme selectivity in the oxidation of acetaminophen. Chem Res Toxicol 1988; 1:47–52.MEDLINE
- 13, , , , . Oxidation of acetaminophen to nacetylpaminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 1993; 45:1563–1569.MEDLINE
- 14, , , , . Zonation of acetaminophen metabolism and cytochrome P450 2E1–mediated toxicity studied in isolated periportal and perivenous hepatocytes. Biochem Pharmacol 1993; 45:1251–1259.MEDLINE
- 15, , , , . Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973; 187:211–217.MEDLINE
- 16, , , . Analysis of acetaminophen metabolites in urine by high performance liquid chromatography with UV and amperometric detection. J Chromatogr 1982; 227:453–462.MEDLINE
- 17, , , , , . The toxicity of acetaminophen and N-acetyl-p-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. J Biol Chem 1985; 260:13035–13040.MEDLINE
- 18, , . Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism based prevention. Drug Metab Rev 1992; 24:367–407.MEDLINE
- 19. Molecular mechanisms of the hepatotoxicity caused by acetaminophen [Review]. Semin Liver Dis 1990; 10:267–278.MEDLINE
- 20, , , . Cytochrome P450 distribution in rat liver and the effect of sodium phenobarbitone administration. Chem Biol Interact 1978; 20:299–310.MEDLINE
- 21, , . Glutathione replenishment capacity is lower in isolated perivenous than in periportal hepatocytes. Biochem J 1988; 254:411–417.MEDLINE
- 22, , , , . Drug metabolism by periportal and perivenous rat hepatocytes. Comparison of phase I and phase II reactions and their inducibility during culture. Biochem Pharmacol 1989; 38:1329–1334.MEDLINE
- 23, , , . Transcriptional control of CYP2E1 in the perivenous liver region and during starvation. Biochem Biophys Res Commun 1990; 173:331–338.MEDLINE
- 24, , , . Studies on the mechanism of paracetamol induced protection against paracetamol hepatotoxicity. Toxicology 1979; 12:121–133.MEDLINE
- 25, , . Serum enzyme activities and hepatic triglyceride levels in acute and subacute acetaminophen treated rats. Toxicology 1976; 6:9–20.MEDLINE
- 26, . Longterm administration of toxic doses of paracetamol (acetaminophen) to rats. Liver 1988; 8:151–156.MEDLINE
- 27, , , . Pharmacological studies on the in vivo cataractogenicity of APAP in mice and rabbits. Fund Appl Toxicol 1988; 10:596–606.
- 28, . Purification and characterization of a hepatic mitochondrial cytochrome P450 active in aflatoxin B1 metabolism. Biochemistry 1989; 28:7546–7554.MEDLINE
- 29, . Carbon monoxide pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 1964; 239:2370–2378.
- 30, , . The induction and competitive inhibition of a high affinity microsomal nitrosodimethylamine demethylase by ethanol. Carcinogenesis 1982; 3:1457–1461.MEDLINE
- 31
- 32, , , , , . Ethoxy, pentoxy and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450. Biochem Pharmacol 1985; 34:3337–3345.MEDLINE
- 33, , . Paracetamol metabolism following overdosage: application of high performance liquid chromatography. J Pharm Pharmacol 1977; 29:235–237.MEDLINE
- 34
- 35
- 36, , , , . A sensitive immunochemical assay for acetaminophen-protein adducts. J Pharmacol Exp Ther 1987; 241:527–533.MEDLINE
- 37, , , . Immunoblot analysis of protein containing 3(cysteinSyl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen treated mice. Toxicol Appl Pharmacol 1990; 104:521–532.MEDLINE
- 38, , , , . Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay. J Pharmacol Exp Ther 1989; 248:182–189.MEDLINE
- 39, , . Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin Chem 1978; 24:58–73.MEDLINE
- 40. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27:502–522.MEDLINE
- 41, , , . Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–275.
- 42, , , , , , . Immunohistochemical localization and quantification of the 3(cysteinSyl)acetaminophen protein adduct in acetaminophen hepatotoxicity. Am J Pathol 1991; 138:359–371.MEDLINE
- 43, , , , . Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats. Environ Health Perspect 1993; 101:199–205.MEDLINE
- 44, , , . Metabolic basis for high paracetamol dosage without hepatic injury: a case study. Hum Exp Toxicol 1995; 14:8–12.MEDLINE
- 45, . Compound opioid/paracetamol analgesics: misuse and dependence. Br J Clin Practice 1995; 49:268–269.
- 46, , , , , . Mechanism of paracetamol toxicity [Letter]. Lancet 1990; 335:268–269.
- 47, , , . N-Acetyl-p-benzoquinone imine: a cytochrome P450 mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A 1984; 81:1327–1331.MEDLINE
- 48. . . . Species differences in the hepatotoxicity of paracetamol are due to differences in the rate of conversion to its cytotoxic metabolite. Biochem Pharmacol 1987; 36:1041–1052.MEDLINE
- 49, , , , , , , et al. Therapeutic doses of codeine have no effect on acetaminophen clearance or metabolism. Eur J Clin Pharmacol 1988; 35:109–111.MEDLINE
- 50, , , , , . Immunochemical quantitation of 3(cysteinSyl)acetaminophen adducts in serum and liver proteins of acetaminophen treated mice. J Pharmacol Exp Ther 1989; 248:190–196.MEDLINE
- 51, , , , , . Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 1973; 187:195–202.MEDLINE
- 52, , . Hepatic protein arylation, GSH depletion, and metabolite profiles of APAP and a non-hepatic regioisomer, 3′-hydroxyacetanilide, in the mouse. Drug Metab Dispos 1990; 18:765–770.MEDLINE
- 53, , . Glutathione alterations in rat liver after acute and subacute oral administration of paracetamol. Clin Exp Pharmacol Physiol 1977; 4:1–6.MEDLINEDirect Link:
- 54, , , , . Centrilobular expression of ethanol-inducible cytochrome P450 (IIE1) in rat liver. Biochem Biophys Res Commun 1988; 157:55–60.MEDLINE
- 55, , , , . Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur J Biochem 1992; 204:407–412.MEDLINEDirect Link:
- 56
- 57, . Effect of pretreatment of rats with carbon tetrachloride on tolerence development. Toxicol Appl Pharmacol 1970; 17:83–97.MEDLINE
- 58, . Reduction of carbon tetrachloride toxicity by prior administration of a single dose in mice and rats. Br J Exp Pathol 1975; 56:172–179.MEDLINE
- 59, , . Autoprotection: stimulated tissue repair permits recovery from injury. Biochem Toxicol 1994; 9:131–139.Direct Link:
- 60, , , , . Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality. Hepatology 1995; 21:477–486.MEDLINE
- 61, , , . Hepatic regenerative enzyme activity after pericentral and periportal lobular toxic injury. Toxicol Appl Pharmacol 1986; 86:147–158.MEDLINE
- 62, , , , . Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 1996; 271:12063–12067.MEDLINE
- 63, , . Redox signaling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem Pharmacol 1995; 50:735–741.MEDLINE
- 64, , . Study of gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods 1997; 11:301–312.MEDLINE
- 65, , , . Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J Pharmacol Exp Ther 1996; 279:1470–1483.MEDLINE
- 66, , , , . Ca2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J 1993; 7:453–463.MEDLINE
- 67, , . Effect of N-acetylcysteine on heat shock protein induction by acetaminophen in mouse liver. J Pharmacol Exp Ther 1998; 286:519–524.MEDLINE